APA (7th ed.) Citation

I, L., D, C., & T, M. (2026). Balancing Access and Value in Multi-Indication Medicines: Implications of PD-L1 Broad Listings in Australia. PharmacoEconomics. https://doi.org/10.1007/s40273-026-01635-y

Chicago Style (17th ed.) Citation

I, Luc, Carter D, and Merlin T. "Balancing Access and Value in Multi-Indication Medicines: Implications of PD-L1 Broad Listings in Australia." PharmacoEconomics 2026. https://doi.org/10.1007/s40273-026-01635-y.

MLA (9th ed.) Citation

I, Luc, et al. "Balancing Access and Value in Multi-Indication Medicines: Implications of PD-L1 Broad Listings in Australia." PharmacoEconomics, 2026, https://doi.org/10.1007/s40273-026-01635-y.